Ethyl 2-(7-methyl-5-oxo-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl)acetate

Catalog No. :
ACIXEA111
CAS No. :
145694-86-6
Molecular Formula :
C10H11N3O3S
Molecular Weight :
253.28

IUPAC Name:ethyl 2-(7-methyl-5-oxo-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl)acetate

Ethyl 2-(7-methyl-5-oxo-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$155.00Login to see priceInquiryInquiry
1g95%$389.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(7-methyl-5-oxo-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl)acetate
IUPAC Nameethyl 2-(7-methyl-5-oxo-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl)acetate
MDL No.MFCD00620685
Molecular FormulaC10H11N3O3S
Molecular Weight253.28
SMILESO=C(OCC)CC(S1)=NN(C1=NC(C)=C2)C2=O
InChI KeyMQMVOCWCDBOYOM-UHFFFAOYSA-N
Synonym2-(5-keto-7-methyl-[1,3,4]thiadiazolo[4,5-a]pyrimidin-2-yl)acetic acid ethyl ester;2-(7-methyl-5-oxo-[1,3,4]thiadiazolo[4,5-a]pyrimidin-2-yl)acetic acid ethyl ester;ethyl (7-methyl-5-oxo-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl)acetate;AIDS147521;AIDS-147521;ChemDiv2_003457;ethyl 2-(7-methyl-5-oxo-[1,3,4]thiadiazolo[4,5-a]pyrimidin-2-yl)acetate;ethyl 2-(7-methyl-5-oxo-[1,3,4]thiadiazolo[4,5-a]pyrimidin-2-yl)ethanoate
CAS No.145694-86-6

Synthetic Route by SureRoute

1. ACIXEA111 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIXEA111 route product structure diagram
    ACIXEA111145694-86-6
Inquiry

2. ACIXEA111 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIXEA111 route product structure diagram
    ACIXEA111145694-86-6
Inquiry

Comments (0)